| 000 | 01671 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518045228.0 | ||
| 264 | 0 | _c20200707 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1098-5514 | ||
| 024 | 7 |
_a10.1128/JVI.00579-19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPasin, Chloé | |
| 245 | 0 | 0 |
_aDynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation. _h[electronic resource] |
| 260 |
_bJournal of virology _c09 2019 |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Viral _ximmunology |
| 650 | 0 | 4 |
_aAntibody Formation _ximmunology |
| 650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xmethods |
| 650 | 0 | 4 |
_aEbola Vaccines _ximmunology |
| 650 | 0 | 4 |
_aEbolavirus _ximmunology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhagic Fever, Ebola _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 |
_aImmunity, Humoral _xdrug effects |
| 650 | 0 | 4 |
_aImmunization, Secondary _xmethods |
| 650 | 0 | 4 | _aKenya |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 | _aTanzania |
| 650 | 0 | 4 | _aUganda |
| 650 | 0 | 4 | _aUnited Kingdom |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aBalelli, Irene | |
| 700 | 1 | _aVan Effelterre, Thierry | |
| 700 | 1 | _aBockstal, Viki | |
| 700 | 1 | _aSolforosi, Laura | |
| 700 | 1 | _aPrague, Mélanie | |
| 700 | 1 | _aDouoguih, Macaya | |
| 700 | 1 | _aThiébaut, Rodolphe | |
| 773 | 0 |
_tJournal of virology _gvol. 93 _gno. 18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.00579-19 _zAvailable from publisher's website |
| 999 |
_c29839771 _d29839771 |
||